scorecardresearch
Thursday, October 31, 2024
Support Our Journalism
HomeHealthBharat Biotech secures Letter of Comfort from govt for additional 45 lakh...

Bharat Biotech secures Letter of Comfort from govt for additional 45 lakh vaccine doses

Out of the 45 lakh doses, over 8 lakh will be supplied to friendly countries such as Mauritius, Philippines and Myanmar, free of cost as a goodwill gesture.

Follow Us :
Text Size:

Hyderabad: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said.

Out of the 45 lakh doses, the city-based vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture sources added.

“The company was given a fresh letter of comfort recently for supplying another 45 lakh doses of Covaxin.

The doses will be dispatched as when the Ministry places orders with the company,” sources told PTI.

After having received the government purchase order for 55lakh doses, BharatBiotechshipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow, it said.

Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India.

Sources further said the supplies from the company depend on the orders being placed by the government.


Also read: India to export Covid vaccines free of cost to its neighbours as a ‘goodwill gesture’


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular